Marta Rubio, SpainIQVIA HEOR RWES
Poster Author Of 1 e-Poster
ECONOMIC BURDEN OF PNEUMOCOCCAL DISEASE IN INDIVIDUALS AGED 15 YEARS AND OLDER IN SPAIN: AN APPROXIMATION BASED ON THE CONJUNTO MÍNIMO DE DATOS-HOSPITALIZACIÓN (CMBD-H)
Author Of 1 Presentation
ECONOMIC BURDEN OF PNEUMOCOCCAL DISEASE IN INDIVIDUALS AGED 15 YEARS AND OLDER IN SPAIN: AN APPROXIMATION BASED ON THE CONJUNTO MÍNIMO DE DATOS-HOSPITALIZACIÓN (CMBD-H) (ID 780)
Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, being the most common etiological pathogen of pneumonia, meningitis and bacteremia. This study assessed the healthcare resource utilization and costs associated with inpatient admissions for pneumonia and invasive pneumococcal disease (IPD) in individuals aged 15 years and older in Spain during 2015.
A retrospective, descriptive study was conducted using Conjunto Mínimo de Datos-Hospitalización (CMBD-H), a publicly available database provided by the Spanish Ministry of Health capturing approximately 90% of hospitalization episodes.
The economic burden of pneumococcal disease was calculated by multiplying the average cost associated with an inpatient admission for pneumonia or IPD by the number of each type of episode. Additionally, the length of stay (days of hospitalization) due to pneumococcal disease was estimated
The aggregated annual economic burden of pneumococcal disease was 54.1 million euros ($60.1 million) These represented over 97,390 hospitalization days, 80% of which were associated with pneumococcal pneumonia. Pneumococcal meningitis has the highest average cost per episode, 10,706 euros ($11,904) followed by the average cost of a septicemia episode, 9,338 euros ($10,382).
These results demonstrate the substantial economic impact of pneumococcal disease on the Spanish National Health System.